Chemicals and Drugs

Ultralente Insulin

A preparation of insulin and zinc chloride in the form of a crystalline suspension. Typically the duration of ultralente insulin activity lasts between 18-30 hours after dosage.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A preparation of insulin and zinc chloride in the form of a crystalline suspension. Typically the duration of ultralente insulin activity lasts between 18-30 hours after dosage.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

Synonyms

1 entry terms
  • Insulin, Ultralente

MeSH Record

Aspects Covered

26 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

2012; use INSULIN, LONG-ACTING 1966-2011

MeSH Record

Previous Indexing

  • Insulin, Long-Acting (1966-2011)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Ultralente Insulin. Medical Subject Headings (MeSH). 2026. Unique ID D061406. http://id.nlm.nih.gov/mesh/2026/D061406
  2. Ultralente Insulin. In: Wikipedia. https://en.wikipedia.org/wiki/Ultralente_insulin
  3. Ultralente Insulin. In: Wikidata. https://www.wikidata.org/wiki/Q7880550